Jennifer Furin

5 ta ish

Harvard University

1. Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India

   Petros Isaakidis, Roma Paryani, Samsuddin Khan +5

   MaqolaOAOchiq kirish20133 iqtibos

   ABIABI:AkademIndex/2026.other.135310

2. Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis

   Ilse Tack, Asnake Yohannes Dumicho, Liesbet Ohler +6

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.006854

3. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

   Keertan Dheda, Tawanda Gumbo, Gary Maartens +39

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.279676

4. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

   Elizabeth Harausz, Anthony J. Garcia‐Prats, Stephanie J. Law +47

   Sharh maqolaOAOchiq kirish20181 iqtibos

   ABIABI:AkademIndex/2026.other.135315

5. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

   Anthony J. Garcia‐Prats, Maria Garcia‐Cremades, Vivian Cox +97

   Sharh maqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe Lancet Child & Adolescent Health20250 iqtibos

   ABIABI:AkademIndex/2025.review-article.000036